Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seasonal Malaria Vaccine Delivery Research in Guinea
PACTR202505741634273Phase 4Not yet recruiting
- Sponsor
- Université des Sciences, des Techniques et des Technologies de Bamako
- Start
- Feb 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of plasmodium falciparum and hepatitis b vaccine (recombinant, adjuvanted) in malaria (2 arms), sponsored by Université des Sciences, des Techniques et des Technologies de Bamako. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
plasmodium falciparum and hepatitis b vaccine (recombinant, adjuvanted)
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202505741634273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202505741634273.